Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05815628 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Next-Generation-Sequencing Approach to Neutropenic Sepsis

Study acronym: NEXUS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 8, 2025 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Nov 30, 2025 to Sep 30, 2026
    • Study completion date: Jan 1, 2026 to Nov 1, 2026
    • Site details revised at 1 of 6 sites
    v6
  2. Primary completion date: May 1, 2025 to Nov 30, 2025
    • Study sites: 1 to 6
    • Study completion date: Jul 1, 2025 to Jan 1, 2026
    v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 1, 2024 to Jun 5, 2024
    v4
  4. Start date: May 1, 2023 to Jun 1, 2024v3
  5. Study Identification, Study Statusv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this prospective, observational, non-interventional, multi-centre study of the diagnostic use of DISQVER in neutropenic patients with FN is to provide further evidence of the efficacy of an NGS-based approach for detecting bloodstream infection in neutropenic patients.
Trial Details
NCT Number NCT05815628
Lead Sponsor Boris Böll
Collaborators: Noscendo GmbH
Conditions
(from sponsor)		 Febrile Neutropenia
Related terms Febrile Neutropenia
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov